CVS Health (NYSE: CVS) reported Q2 EPS of $1.81, $0.35 better than the analyst estimate of $1.46. Revenue for the quarter came in at $98.9 billion versus the consensus estimate of $94.73 billion.

GUIDANCE:

CVS Health sees FY2025 EPS of $6.30-$6.40, versus the consensus of $6.12.

For earnings history and earnings-related data on CVS Health (CVS) click here.